<abstract xmlns="http://www.w3.org/1999/xhtml">
<sec id="j_sjph-2023-0004_s_006"><h3>Introduction</h3>
<p>Gestational diabetes (GDM) is one of the most common complications in pregnancy, with a prevalence that continues to rise. At the time of the COVID-19 epidemic, immediate reorganisation and adjustment of the system was needed. Telemedicine support was offered in order to provide high-quality treatment to pregnant women. However, the success of the treatment is unknown. We therefore aimed to evaluate COVID-19 epidemic effects on pregnancy outcomes in GDM.</p>
</sec>
<sec id="j_sjph-2023-0004_s_007"><h3>Methods</h3>
<p>The maternal outcomes (insulin treatment, gestational weight gain, caesarean section, hypertensive disorders) and perinatal outcomes (rates of large and small for gestational age, preterm birth and a composite child outcome) of women visiting a university hospital diabetes clinic from March to December 2020 were compared with those treated in the same period in 2019.</p>
</sec>
<sec id="j_sjph-2023-0004_s_008"><h3>Results</h3>
<p>Women diagnosed with GDM during the COVID-19 epidemic (n=417), were diagnosed earlier (23.9 [11.7–26.0] vs. 25.1 [21.8–26.7] gestational week), had higher fasting glucose (5.2 [5.0–5.4] vs. 5.1 [4.8–5.3] mmol/l) and earlier pharmacological therapy initiation, and had achieved lower HbA1c by the end of followup (5.1% (32.2 mmol/mol) [4.9% (30.1 mmol/mol)–5.4% (35.0 mmol/mol)] vs. 5.2% (33.3 mmol/mol) [5.0% (31.1 mmol/mol) – 5.4%·(35.5 mmol/mol)], p&lt;0.001) compared to a year before (n=430). No significant differences in perinatal outcomes were found.</p>
</sec>
<sec id="j_sjph-2023-0004_s_009"><h3>Conclusions</h3>
<p>Although GDM was diagnosed at an earlier gestational age and higher fasting glucose concentration was present at the time of diagnosis, the COVID-19 epidemic did not result in worse glucose control during pregnancy or worse pregnancy outcomes in Slovenia.</p>
</sec>
</abstract>

Introduction
Gestational diabetes (GDM) is one of the most common complications in pregnancy, with a prevalence that continues to rise. At the time of the COVID-19 epidemic, immediate reorganisation and adjustment of the system was needed. Telemedicine support was offered in order to provide high-quality treatment to pregnant women. However, the success of the treatment is unknown. We therefore aimed to evaluate COVID-19 epidemic effects on pregnancy outcomes in GDM.

Methods
The maternal outcomes (insulin treatment, gestational weight gain, caesarean section, hypertensive disorders) and perinatal outcomes (rates of large and small for gestational age, preterm birth and a composite child outcome) of women visiting a university hospital diabetes clinic from March to December 2020 were compared with those treated in the same period in 2019.

Results
Women diagnosed with GDM during the COVID-19 epidemic (n=417), were diagnosed earlier (23.9 [11.7–26.0] vs. 25.1 [21.8–26.7] gestational week), had higher fasting glucose (5.2 [5.0–5.4] vs. 5.1 [4.8–5.3] mmol/l) and earlier pharmacological therapy initiation, and had achieved lower HbA1c by the end of followup (5.1% (32.2 mmol/mol) [4.9% (30.1 mmol/mol)–5.4% (35.0 mmol/mol)] vs. 5.2% (33.3 mmol/mol) [5.0% (31.1 mmol/mol) – 5.4%·(35.5 mmol/mol)], p<0.001) compared to a year before (n=430). No significant differences in perinatal outcomes were found.

Conclusions
Although GDM was diagnosed at an earlier gestational age and higher fasting glucose concentration was present at the time of diagnosis, the COVID-19 epidemic did not result in worse glucose control during pregnancy or worse pregnancy outcomes in Slovenia.

Maternal and perinatal outcomes during the COVID-19 epidemic in pregnancies complicated by gestational diabetes

Slovenian Journal of Public Health

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Zapleti pri porodu pri nosečnostni sladkorni bolezni v Sloveniji v času epidemije COVID-19

Introduction
Gestational diabetes (GDM) is one of the most common complications in pregnancy, with a prevalence that continues to rise. At the time of the...

Maternal and perinatal outcomes during the COVID-19 epidemic in pregnancies complicated by gestational diabetes

Article Category: Original scientific article

Published Online: Jan 03, 2023

Page range: 22 - 29

Received: Apr 15, 2022

Accepted: Nov 14, 2022

DOI: https://doi.org/10.2478/sjph-2023-0004

Keywords
gestational diabetes, COVID-19, perinatal outcomes, LGA, early screening, telemedicine

© 2023 National Institute of Public Health, Slovenia, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Maternal and perinatal outcomes during the COVID-19 epidemic in pregnancies complicated by gestational diabetes

Article Category: Original scientific article

Published Online: Jan 03, 2023

Page range: 22 - 29

Received: Apr 15, 2022

Accepted: Nov 14, 2022

DOI: https://doi.org/10.2478/sjph-2023-0004

Keywordsgestational diabetes, COVID-19, perinatal outcomes, LGA, early screening, telemedicine

© 2023 National Institute of Public Health, Slovenia, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Keywords
gestational diabetes, COVID-19, perinatal outcomes, LGA, early screening, telemedicine